142 related articles for article (PubMed ID: 38453442)
21. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma.
Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J
Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
23. The expression of FAT1 is associated with overall survival in children with medulloblastoma.
Yu J; Li H
Tumori; 2017 Jan; 103(1):44-52. PubMed ID: 27834469
[TBL] [Abstract][Full Text] [Related]
24. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
25. CENPF Upregulation is Associated with Immunosuppressive Status and Poor Clinical Outcomes in Lung Adenocarcinoma Validated by qRT-PCR.
Xu Z; Xu D; You Z; Tian W
Comb Chem High Throughput Screen; 2024; 27(1):78-89. PubMed ID: 37287300
[TBL] [Abstract][Full Text] [Related]
26. Favorable immune checkpoint inhibitor outcome of patients with melanoma and NSCLC harboring FAT1 mutations.
Zhang W; Tang Y; Guo Y; Kong Y; Shi F; Sheng C; Wang S; Wang Q
NPJ Precis Oncol; 2022 Jun; 6(1):46. PubMed ID: 35739249
[TBL] [Abstract][Full Text] [Related]
27. Prognostic and immunological potential of PPM1G in lung adenocarcinoma.
Yin R; Qu L; Wang Z; Tang J; Gu H; Wang X; Yang D; Du P; Dong M
Mol Med Rep; 2023 Aug; 28(2):. PubMed ID: 37387407
[TBL] [Abstract][Full Text] [Related]
28. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
[No Abstract] [Full Text] [Related]
29. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L
Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of FAT4 suppress metastasis of lung adenocarcinoma through regulating MAPK pathway and associated with immune cells infiltration.
Ning Y; Yang Y; Zheng H; Zhan Y; Zang H; Wen Q; Peng J; Fan S
Cancer Med; 2023 Jan; 12(2):1616-1629. PubMed ID: 35770846
[TBL] [Abstract][Full Text] [Related]
31. [Mutational Signatures Analysis of Micropapillary Components and Exploration of ZNF469 Gene in Early-stage Lung Adenocarcinoma with Ground-glass Opacities].
Xu Y; Sun Q; Wang S; Zhu H; Dong G; Meng F; Xia Z; You J; Kong X; Wu J; Chen P; Yuan F; Yu X; Ji J; Li Z; Zhu P; Sun Y; Liu T; Yin R; Xu L
Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):889-900. PubMed ID: 38151328
[TBL] [Abstract][Full Text] [Related]
32. The EMT-Related Genes GALNT3 and OAS1 are Associated with Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma.
Luo D; Fang M; Shao L; Wang J; Liang Y; Chen M; Gui X; Yan J; Wang W; Yu L; Fan X; Wu Q
Front Biosci (Landmark Ed); 2023 Oct; 28(10):271. PubMed ID: 37919050
[TBL] [Abstract][Full Text] [Related]
33. [Hsp90AB1 Protein is Overexpressed in Non-small Cell Lung Cancer Tissues
and Associated with Poor Prognosis in Lung Adenocarcinoma Patients].
Wang M; Feng L; Li P; Han N; Gao Y; Xiao T
Zhongguo Fei Ai Za Zhi; 2016 Feb; 19(2):64-9. PubMed ID: 26903158
[TBL] [Abstract][Full Text] [Related]
34. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.
Yu L; Qiao R; Xu J; Han B; Zhong R
Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533
[TBL] [Abstract][Full Text] [Related]
35. Elevated ADAR expression is significantly linked to shorter overall survival and immune infiltration in patients with lung adenocarcinoma.
Hu S; Wang F; Yang J; Xu X
Math Biosci Eng; 2023 Sep; 20(10):18063-18082. PubMed ID: 38052548
[TBL] [Abstract][Full Text] [Related]
36. PKM2 is a potential prognostic biomarker and related to immune infiltration in lung cancer.
Yin L; Shi J; Zhang J; Lin X; Jiang W; Zhu Y; Song Y; Lu Y; Ma Y
Sci Rep; 2023 Dec; 13(1):22243. PubMed ID: 38097666
[TBL] [Abstract][Full Text] [Related]
37. Expression of connexin 43 and E-cadherin protein and mRNA in non-small cell lung cancers in Chinese patients.
Zhao JQ; Sun FJ; Liu SS; Yang J; Wu YQ; Li GS; Chen QY; Wang JX
Asian Pac J Cancer Prev; 2013; 14(2):639-43. PubMed ID: 23621211
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
39. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ
Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
[No Abstract] [Full Text] [Related]
40. KAT2B is an immune infiltration-associated biomarker predicting prognosis and response to immunotherapy in non-small cell lung cancer.
Zhou X; Wang N; Zhang Y; Yu H; Wu Q
Invest New Drugs; 2022 Feb; 40(1):43-57. PubMed ID: 34499335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
